Minority Investor for Biopharma Specialist BEESY

In the US, biopharma-focused behavioral-science research and tech firm BEESY has received a minority investment from Denali Growth Partners (DGP), allowing it to continue investing in product innovation, and accelerate its growth across new geographies and therapeutic areas.

BEESY, headquartered in New Jersey and founded in 2018 by former Ipsos US Marketing chief Elys Roberts, helps clients in healthcare and biopharma sectors understand the non-conscious drivers behind customer decision-making, and thereby market more effectively. The new partnership will help it continue investment in AI-based product innovation and internal efficiencies, offering clients faster, more scalable translation of behavioral insights into actionable commercial strategies.

CEO Roberts (pictured) says of the news, 'We're excited to partner with DGP as we build the next phase of BEESY. We've experienced very rapid growth to date and see a massive period of disruption coming in our industry - this represents a significant window of opportunity for BEESY. From our earliest conversations, it was clear DGP shares our ambition to scale a platform that turns our insights into action. With DGP's experience across life sciences and healthcare IT, we're well positioned to accelerate product and service development, and deepen the impact we deliver to our partners.'

Jesse Lane, Managing Partner at DGP says BEESY delivers differentiated thinking and produces work that teams can act on immediately, adding: 'BEESY is building a distinct position at the intersection of behavioral science, AI-enabled insights, and practical commercial execution.'

Web site: www.beesystrategy.com .